MPOX Vaccine w Associate Professor Mark Thomas, Molecular Medicine and Pathology, University of Auckland

The New Zealand government has recently provisionally approved the Monkeypox, or MPOX vaccine in New Zealand. This comes after two new cases being linked to the Queenstown Winter Pride festival. 

The overall risk of MPOX to New Zealand still remains low, despite the World Health Organisation Director-General declaring MPOX outbreak a public emergency of International Concern. Despite this, the virus may still prove deadly without proper vaccination or treatment.

Sasha spoke to Associate Professor Mark Thomas from the University of Auckland Molecular Medicine and Pathology about the recent adoption of an MPOX vaccine.